BRITISH JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1242219, encodeId=5a121242219b0, content=偏重的研究方向：基础研究;肿瘤分子诊断 经验分享：第九天under consideration，感觉跟别人的投稿进度比，效率有点慢哎，送不送外审要好久哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=219a5283754, createdName=胸心外科大辣鸡, createdTime=Wed Aug 31 09:48:26 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205029, encodeId=f89e120502967, content=现在要求链接所有通讯作者的ORCID号，但是投稿系统只有一个能标通讯作者有链接，另一个咋办啊？还有其他可以添加ORCID号的地方吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/07/6b605841361be17ba96637bccdbdccb4.jpg, createdBy=eaa62374501, createdName=122fdc42m84暂无昵称, createdTime=Tue Mar 22 20:59:37 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544294, encodeId=d79e544294ed, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577327, encodeId=14d55e73276b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2018 IF：5.922；2019 IF：5.416 从今年4月14日投稿，目前还没有online，过了国庆去交版面费（3300刀）做的是分子实验，5张figure+1个table，每个里面有4-7个小figure。附加材料有2张table。等待分配审稿人是最纠结的，大概等了2个月，审稿人意见比较尖锐，补了几个小实验，大概花了半个月在措辞怎么回复审稿人。运气还算好，修回后没有二修就被接收了。杂志对语言要求比较高，一句话编辑让我反复修改了3次才达到要求。投稿 Under submission 14th Apr 19 Author Approved Converted Files 16th Apr 19 Under consideration 16th Apr 19 Under review 13th Jun 19 Under consideration 1st Jul 19 Decision made 2nd Jul 19 Waiting for Revision 2nd Jul 19 Revision Received 23rd Jul 19 修回 Under submission 23rd Jul 19 Author Approved Converted Files 23rd Jul 19 Under consideration 23rd Jul 19 Under review 5th Aug 19 Under consideration 14th Aug 19 Decision made 19th Aug 19 Waiting for Revision 19th Aug 19 Revision Received 19th Aug 19 接收 Under submission 19th Aug 19 Author Approved Converted Files 21st Aug 19 Under consideration 21st Aug 19 Decision made 27th Sep 19, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddf64839631, createdName=chenqun9408, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799863, encodeId=e357e998636f, content=投稿10天，发邮件让提交consent to participate ，然后把国自然的伦理批件提交，过了2天，又给退回还让交consent to participate ，这个怎么破？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Thu Jun 25 21:42:08 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602110, encodeId=26b9602110cb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿6个月被拒了，一修三个审稿人，一个拒两个修改后发表，二修两个审稿人，一个拒一个同意发表，编辑建议英文润色。二修后赶上疫情放假，under consideration 了60天。中间让改格式和动物实验的checklist一次，最终被拒，理由是没有好好回复审稿人的意见。现在备选文章较多，就把我pass了。又气又难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Fri Jun 12 10:54:47 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2022-08-31 胸心外科大辣鸡

偏重的研究方向：基础研究;肿瘤分子诊断
经验分享：第九天under consideration，感觉跟别人的投稿进度比，效率有点慢哎，送不送外审要好久哦？

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242219, encodeId=5a121242219b0, content=偏重的研究方向：基础研究;肿瘤分子诊断 经验分享：第九天under consideration，感觉跟别人的投稿进度比，效率有点慢哎，送不送外审要好久哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=219a5283754, createdName=胸心外科大辣鸡, createdTime=Wed Aug 31 09:48:26 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205029, encodeId=f89e120502967, content=现在要求链接所有通讯作者的ORCID号，但是投稿系统只有一个能标通讯作者有链接，另一个咋办啊？还有其他可以添加ORCID号的地方吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/07/6b605841361be17ba96637bccdbdccb4.jpg, createdBy=eaa62374501, createdName=122fdc42m84暂无昵称, createdTime=Tue Mar 22 20:59:37 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544294, encodeId=d79e544294ed, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577327, encodeId=14d55e73276b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2018 IF：5.922；2019 IF：5.416 从今年4月14日投稿，目前还没有online，过了国庆去交版面费（3300刀）做的是分子实验，5张figure+1个table，每个里面有4-7个小figure。附加材料有2张table。等待分配审稿人是最纠结的，大概等了2个月，审稿人意见比较尖锐，补了几个小实验，大概花了半个月在措辞怎么回复审稿人。运气还算好，修回后没有二修就被接收了。杂志对语言要求比较高，一句话编辑让我反复修改了3次才达到要求。投稿 Under submission 14th Apr 19 Author Approved Converted Files 16th Apr 19 Under consideration 16th Apr 19 Under review 13th Jun 19 Under consideration 1st Jul 19 Decision made 2nd Jul 19 Waiting for Revision 2nd Jul 19 Revision Received 23rd Jul 19 修回 Under submission 23rd Jul 19 Author Approved Converted Files 23rd Jul 19 Under consideration 23rd Jul 19 Under review 5th Aug 19 Under consideration 14th Aug 19 Decision made 19th Aug 19 Waiting for Revision 19th Aug 19 Revision Received 19th Aug 19 接收 Under submission 19th Aug 19 Author Approved Converted Files 21st Aug 19 Under consideration 21st Aug 19 Decision made 27th Sep 19, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddf64839631, createdName=chenqun9408, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799863, encodeId=e357e998636f, content=投稿10天，发邮件让提交consent to participate ，然后把国自然的伦理批件提交，过了2天，又给退回还让交consent to participate ，这个怎么破？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Thu Jun 25 21:42:08 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602110, encodeId=26b9602110cb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿6个月被拒了，一修三个审稿人，一个拒两个修改后发表，二修两个审稿人，一个拒一个同意发表，编辑建议英文润色。二修后赶上疫情放假，under consideration 了60天。中间让改格式和动物实验的checklist一次，最终被拒，理由是没有好好回复审稿人的意见。现在备选文章较多，就把我pass了。又气又难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Fri Jun 12 10:54:47 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2022-03-22 122fdc42m84暂无昵称

现在要求链接所有通讯作者的ORCID号，但是投稿系统只有一个能标通讯作者有链接，另一个咋办啊？还有其他可以添加ORCID号的地方吗？

106 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242219, encodeId=5a121242219b0, content=偏重的研究方向：基础研究;肿瘤分子诊断 经验分享：第九天under consideration，感觉跟别人的投稿进度比，效率有点慢哎，送不送外审要好久哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=219a5283754, createdName=胸心外科大辣鸡, createdTime=Wed Aug 31 09:48:26 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205029, encodeId=f89e120502967, content=现在要求链接所有通讯作者的ORCID号，但是投稿系统只有一个能标通讯作者有链接，另一个咋办啊？还有其他可以添加ORCID号的地方吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/07/6b605841361be17ba96637bccdbdccb4.jpg, createdBy=eaa62374501, createdName=122fdc42m84暂无昵称, createdTime=Tue Mar 22 20:59:37 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544294, encodeId=d79e544294ed, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577327, encodeId=14d55e73276b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2018 IF：5.922；2019 IF：5.416 从今年4月14日投稿，目前还没有online，过了国庆去交版面费（3300刀）做的是分子实验，5张figure+1个table，每个里面有4-7个小figure。附加材料有2张table。等待分配审稿人是最纠结的，大概等了2个月，审稿人意见比较尖锐，补了几个小实验，大概花了半个月在措辞怎么回复审稿人。运气还算好，修回后没有二修就被接收了。杂志对语言要求比较高，一句话编辑让我反复修改了3次才达到要求。投稿 Under submission 14th Apr 19 Author Approved Converted Files 16th Apr 19 Under consideration 16th Apr 19 Under review 13th Jun 19 Under consideration 1st Jul 19 Decision made 2nd Jul 19 Waiting for Revision 2nd Jul 19 Revision Received 23rd Jul 19 修回 Under submission 23rd Jul 19 Author Approved Converted Files 23rd Jul 19 Under consideration 23rd Jul 19 Under review 5th Aug 19 Under consideration 14th Aug 19 Decision made 19th Aug 19 Waiting for Revision 19th Aug 19 Revision Received 19th Aug 19 接收 Under submission 19th Aug 19 Author Approved Converted Files 21st Aug 19 Under consideration 21st Aug 19 Decision made 27th Sep 19, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddf64839631, createdName=chenqun9408, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799863, encodeId=e357e998636f, content=投稿10天，发邮件让提交consent to participate ，然后把国自然的伦理批件提交，过了2天，又给退回还让交consent to participate ，这个怎么破？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Thu Jun 25 21:42:08 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602110, encodeId=26b9602110cb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿6个月被拒了，一修三个审稿人，一个拒两个修改后发表，二修两个审稿人，一个拒一个同意发表，编辑建议英文润色。二修后赶上疫情放假，under consideration 了60天。中间让改格式和动物实验的checklist一次，最终被拒，理由是没有好好回复审稿人的意见。现在备选文章较多，就把我pass了。又气又难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Fri Jun 12 10:54:47 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2020-01-08 18900911270haoliangdut

请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表:
有救

138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救

178 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242219, encodeId=5a121242219b0, content=偏重的研究方向：基础研究;肿瘤分子诊断 经验分享：第九天under consideration，感觉跟别人的投稿进度比，效率有点慢哎，送不送外审要好久哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=219a5283754, createdName=胸心外科大辣鸡, createdTime=Wed Aug 31 09:48:26 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205029, encodeId=f89e120502967, content=现在要求链接所有通讯作者的ORCID号，但是投稿系统只有一个能标通讯作者有链接，另一个咋办啊？还有其他可以添加ORCID号的地方吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/07/6b605841361be17ba96637bccdbdccb4.jpg, createdBy=eaa62374501, createdName=122fdc42m84暂无昵称, createdTime=Tue Mar 22 20:59:37 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544294, encodeId=d79e544294ed, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577327, encodeId=14d55e73276b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2018 IF：5.922；2019 IF：5.416 从今年4月14日投稿，目前还没有online，过了国庆去交版面费（3300刀）做的是分子实验，5张figure+1个table，每个里面有4-7个小figure。附加材料有2张table。等待分配审稿人是最纠结的，大概等了2个月，审稿人意见比较尖锐，补了几个小实验，大概花了半个月在措辞怎么回复审稿人。运气还算好，修回后没有二修就被接收了。杂志对语言要求比较高，一句话编辑让我反复修改了3次才达到要求。投稿 Under submission 14th Apr 19 Author Approved Converted Files 16th Apr 19 Under consideration 16th Apr 19 Under review 13th Jun 19 Under consideration 1st Jul 19 Decision made 2nd Jul 19 Waiting for Revision 2nd Jul 19 Revision Received 23rd Jul 19 修回 Under submission 23rd Jul 19 Author Approved Converted Files 23rd Jul 19 Under consideration 23rd Jul 19 Under review 5th Aug 19 Under consideration 14th Aug 19 Decision made 19th Aug 19 Waiting for Revision 19th Aug 19 Revision Received 19th Aug 19 接收 Under submission 19th Aug 19 Author Approved Converted Files 21st Aug 19 Under consideration 21st Aug 19 Decision made 27th Sep 19, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddf64839631, createdName=chenqun9408, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799863, encodeId=e357e998636f, content=投稿10天，发邮件让提交consent to participate ，然后把国自然的伦理批件提交，过了2天，又给退回还让交consent to participate ，这个怎么破？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Thu Jun 25 21:42:08 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602110, encodeId=26b9602110cb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿6个月被拒了，一修三个审稿人，一个拒两个修改后发表，二修两个审稿人，一个拒一个同意发表，编辑建议英文润色。二修后赶上疫情放假，under consideration 了60天。中间让改格式和动物实验的checklist一次，最终被拒，理由是没有好好回复审稿人的意见。现在备选文章较多，就把我pass了。又气又难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Fri Jun 12 10:54:47 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2022-10-26 Glori

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤微环境
经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！

77 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242219, encodeId=5a121242219b0, content=偏重的研究方向：基础研究;肿瘤分子诊断 经验分享：第九天under consideration，感觉跟别人的投稿进度比，效率有点慢哎，送不送外审要好久哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=219a5283754, createdName=胸心外科大辣鸡, createdTime=Wed Aug 31 09:48:26 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205029, encodeId=f89e120502967, content=现在要求链接所有通讯作者的ORCID号，但是投稿系统只有一个能标通讯作者有链接，另一个咋办啊？还有其他可以添加ORCID号的地方吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/07/6b605841361be17ba96637bccdbdccb4.jpg, createdBy=eaa62374501, createdName=122fdc42m84暂无昵称, createdTime=Tue Mar 22 20:59:37 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544294, encodeId=d79e544294ed, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577327, encodeId=14d55e73276b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2018 IF：5.922；2019 IF：5.416 从今年4月14日投稿，目前还没有online，过了国庆去交版面费（3300刀）做的是分子实验，5张figure+1个table，每个里面有4-7个小figure。附加材料有2张table。等待分配审稿人是最纠结的，大概等了2个月，审稿人意见比较尖锐，补了几个小实验，大概花了半个月在措辞怎么回复审稿人。运气还算好，修回后没有二修就被接收了。杂志对语言要求比较高，一句话编辑让我反复修改了3次才达到要求。投稿 Under submission 14th Apr 19 Author Approved Converted Files 16th Apr 19 Under consideration 16th Apr 19 Under review 13th Jun 19 Under consideration 1st Jul 19 Decision made 2nd Jul 19 Waiting for Revision 2nd Jul 19 Revision Received 23rd Jul 19 修回 Under submission 23rd Jul 19 Author Approved Converted Files 23rd Jul 19 Under consideration 23rd Jul 19 Under review 5th Aug 19 Under consideration 14th Aug 19 Decision made 19th Aug 19 Waiting for Revision 19th Aug 19 Revision Received 19th Aug 19 接收 Under submission 19th Aug 19 Author Approved Converted Files 21st Aug 19 Under consideration 21st Aug 19 Decision made 27th Sep 19, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddf64839631, createdName=chenqun9408, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799863, encodeId=e357e998636f, content=投稿10天，发邮件让提交consent to participate ，然后把国自然的伦理批件提交，过了2天，又给退回还让交consent to participate ，这个怎么破？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Thu Jun 25 21:42:08 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602110, encodeId=26b9602110cb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿6个月被拒了，一修三个审稿人，一个拒两个修改后发表，二修两个审稿人，一个拒一个同意发表，编辑建议英文润色。二修后赶上疫情放假，under consideration 了60天。中间让改格式和动物实验的checklist一次，最终被拒，理由是没有好好回复审稿人的意见。现在备选文章较多，就把我pass了。又气又难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Fri Jun 12 10:54:47 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2017-07-16 13805560183

赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦

429 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242219, encodeId=5a121242219b0, content=偏重的研究方向：基础研究;肿瘤分子诊断 经验分享：第九天under consideration，感觉跟别人的投稿进度比，效率有点慢哎，送不送外审要好久哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=219a5283754, createdName=胸心外科大辣鸡, createdTime=Wed Aug 31 09:48:26 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205029, encodeId=f89e120502967, content=现在要求链接所有通讯作者的ORCID号，但是投稿系统只有一个能标通讯作者有链接，另一个咋办啊？还有其他可以添加ORCID号的地方吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/07/6b605841361be17ba96637bccdbdccb4.jpg, createdBy=eaa62374501, createdName=122fdc42m84暂无昵称, createdTime=Tue Mar 22 20:59:37 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544294, encodeId=d79e544294ed, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577327, encodeId=14d55e73276b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2018 IF：5.922；2019 IF：5.416 从今年4月14日投稿，目前还没有online，过了国庆去交版面费（3300刀）做的是分子实验，5张figure+1个table，每个里面有4-7个小figure。附加材料有2张table。等待分配审稿人是最纠结的，大概等了2个月，审稿人意见比较尖锐，补了几个小实验，大概花了半个月在措辞怎么回复审稿人。运气还算好，修回后没有二修就被接收了。杂志对语言要求比较高，一句话编辑让我反复修改了3次才达到要求。投稿 Under submission 14th Apr 19 Author Approved Converted Files 16th Apr 19 Under consideration 16th Apr 19 Under review 13th Jun 19 Under consideration 1st Jul 19 Decision made 2nd Jul 19 Waiting for Revision 2nd Jul 19 Revision Received 23rd Jul 19 修回 Under submission 23rd Jul 19 Author Approved Converted Files 23rd Jul 19 Under consideration 23rd Jul 19 Under review 5th Aug 19 Under consideration 14th Aug 19 Decision made 19th Aug 19 Waiting for Revision 19th Aug 19 Revision Received 19th Aug 19 接收 Under submission 19th Aug 19 Author Approved Converted Files 21st Aug 19 Under consideration 21st Aug 19 Decision made 27th Sep 19, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddf64839631, createdName=chenqun9408, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799863, encodeId=e357e998636f, content=投稿10天，发邮件让提交consent to participate ，然后把国自然的伦理批件提交，过了2天，又给退回还让交consent to participate ，这个怎么破？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Thu Jun 25 21:42:08 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602110, encodeId=26b9602110cb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿6个月被拒了，一修三个审稿人，一个拒两个修改后发表，二修两个审稿人，一个拒一个同意发表，编辑建议英文润色。二修后赶上疫情放假，under consideration 了60天。中间让改格式和动物实验的checklist一次，最终被拒，理由是没有好好回复审稿人的意见。现在备选文章较多，就把我pass了。又气又难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Fri Jun 12 10:54:47 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2019-10-05 chenqun9408

审稿速度:12.0 | 投稿命中率:50.0
经验分享：2018 IF：5.922；2019 IF：5.416 从今年4月14日投稿，目前还没有online，过了国庆去交版面费（3300刀）做的是分子实验，5张figure+1个table，每个里面有4-7个小figure。附加材料有2张table。等待分配审稿人是最纠结的，大概等了2个月，审稿人意见比较尖锐，补了几个小实验，大概花了半个月在措辞怎么回复审稿人。运气还算好，修回后没有二修就被接收了。杂志对语言要求比较高，一句话编辑让我反复修改了3次才达到要求。投稿 Under submission 14th Apr 19 Author Approved Converted Files 16th Apr 19 Under consideration 16th Apr 19 Under review 13th Jun 19 Under consideration 1st Jul 19 Decision made 2nd Jul 19 Waiting for Revision 2nd Jul 19 Revision Received 23rd Jul 19 修回 Under submission 23rd Jul 19 Author Approved Converted Files 23rd Jul 19 Under consideration 23rd Jul 19 Under review 5th Aug 19 Under consideration 14th Aug 19 Decision made 19th Aug 19 Waiting for Revision 19th Aug 19 Revision Received 19th Aug 19 接收 Under submission 19th Aug 19 Author Approved Converted Files 21st Aug 19 Under consideration 21st Aug 19 Decision made 27th Sep 19

221 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242219, encodeId=5a121242219b0, content=偏重的研究方向：基础研究;肿瘤分子诊断 经验分享：第九天under consideration，感觉跟别人的投稿进度比，效率有点慢哎，送不送外审要好久哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=219a5283754, createdName=胸心外科大辣鸡, createdTime=Wed Aug 31 09:48:26 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205029, encodeId=f89e120502967, content=现在要求链接所有通讯作者的ORCID号，但是投稿系统只有一个能标通讯作者有链接，另一个咋办啊？还有其他可以添加ORCID号的地方吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/07/6b605841361be17ba96637bccdbdccb4.jpg, createdBy=eaa62374501, createdName=122fdc42m84暂无昵称, createdTime=Tue Mar 22 20:59:37 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544294, encodeId=d79e544294ed, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577327, encodeId=14d55e73276b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2018 IF：5.922；2019 IF：5.416 从今年4月14日投稿，目前还没有online，过了国庆去交版面费（3300刀）做的是分子实验，5张figure+1个table，每个里面有4-7个小figure。附加材料有2张table。等待分配审稿人是最纠结的，大概等了2个月，审稿人意见比较尖锐，补了几个小实验，大概花了半个月在措辞怎么回复审稿人。运气还算好，修回后没有二修就被接收了。杂志对语言要求比较高，一句话编辑让我反复修改了3次才达到要求。投稿 Under submission 14th Apr 19 Author Approved Converted Files 16th Apr 19 Under consideration 16th Apr 19 Under review 13th Jun 19 Under consideration 1st Jul 19 Decision made 2nd Jul 19 Waiting for Revision 2nd Jul 19 Revision Received 23rd Jul 19 修回 Under submission 23rd Jul 19 Author Approved Converted Files 23rd Jul 19 Under consideration 23rd Jul 19 Under review 5th Aug 19 Under consideration 14th Aug 19 Decision made 19th Aug 19 Waiting for Revision 19th Aug 19 Revision Received 19th Aug 19 接收 Under submission 19th Aug 19 Author Approved Converted Files 21st Aug 19 Under consideration 21st Aug 19 Decision made 27th Sep 19, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddf64839631, createdName=chenqun9408, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799863, encodeId=e357e998636f, content=投稿10天，发邮件让提交consent to participate ，然后把国自然的伦理批件提交，过了2天，又给退回还让交consent to participate ，这个怎么破？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Thu Jun 25 21:42:08 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602110, encodeId=26b9602110cb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿6个月被拒了，一修三个审稿人，一个拒两个修改后发表，二修两个审稿人，一个拒一个同意发表，编辑建议英文润色。二修后赶上疫情放假，under consideration 了60天。中间让改格式和动物实验的checklist一次，最终被拒，理由是没有好好回复审稿人的意见。现在备选文章较多，就把我pass了。又气又难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Fri Jun 12 10:54:47 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2020-06-25 1245e6c8m84暂无昵称

投稿10天，发邮件让提交consent to participate ，然后把国自然的伦理批件提交，过了2天，又给退回还让交consent to participate ，这个怎么破？

293 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242219, encodeId=5a121242219b0, content=偏重的研究方向：基础研究;肿瘤分子诊断 经验分享：第九天under consideration，感觉跟别人的投稿进度比，效率有点慢哎，送不送外审要好久哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=219a5283754, createdName=胸心外科大辣鸡, createdTime=Wed Aug 31 09:48:26 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205029, encodeId=f89e120502967, content=现在要求链接所有通讯作者的ORCID号，但是投稿系统只有一个能标通讯作者有链接，另一个咋办啊？还有其他可以添加ORCID号的地方吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/07/6b605841361be17ba96637bccdbdccb4.jpg, createdBy=eaa62374501, createdName=122fdc42m84暂无昵称, createdTime=Tue Mar 22 20:59:37 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544294, encodeId=d79e544294ed, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577327, encodeId=14d55e73276b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2018 IF：5.922；2019 IF：5.416 从今年4月14日投稿，目前还没有online，过了国庆去交版面费（3300刀）做的是分子实验，5张figure+1个table，每个里面有4-7个小figure。附加材料有2张table。等待分配审稿人是最纠结的，大概等了2个月，审稿人意见比较尖锐，补了几个小实验，大概花了半个月在措辞怎么回复审稿人。运气还算好，修回后没有二修就被接收了。杂志对语言要求比较高，一句话编辑让我反复修改了3次才达到要求。投稿 Under submission 14th Apr 19 Author Approved Converted Files 16th Apr 19 Under consideration 16th Apr 19 Under review 13th Jun 19 Under consideration 1st Jul 19 Decision made 2nd Jul 19 Waiting for Revision 2nd Jul 19 Revision Received 23rd Jul 19 修回 Under submission 23rd Jul 19 Author Approved Converted Files 23rd Jul 19 Under consideration 23rd Jul 19 Under review 5th Aug 19 Under consideration 14th Aug 19 Decision made 19th Aug 19 Waiting for Revision 19th Aug 19 Revision Received 19th Aug 19 接收 Under submission 19th Aug 19 Author Approved Converted Files 21st Aug 19 Under consideration 21st Aug 19 Decision made 27th Sep 19, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddf64839631, createdName=chenqun9408, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799863, encodeId=e357e998636f, content=投稿10天，发邮件让提交consent to participate ，然后把国自然的伦理批件提交，过了2天，又给退回还让交consent to participate ，这个怎么破？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Thu Jun 25 21:42:08 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602110, encodeId=26b9602110cb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿6个月被拒了，一修三个审稿人，一个拒两个修改后发表，二修两个审稿人，一个拒一个同意发表，编辑建议英文润色。二修后赶上疫情放假，under consideration 了60天。中间让改格式和动物实验的checklist一次，最终被拒，理由是没有好好回复审稿人的意见。现在备选文章较多，就把我pass了。又气又难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Fri Jun 12 10:54:47 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2020-06-12 18900911270haoliangdut

审稿速度:2.0 | 投稿命中率:25.0
经验分享：投稿6个月被拒了，一修三个审稿人，一个拒两个修改后发表，二修两个审稿人，一个拒一个同意发表，编辑建议英文润色。二修后赶上疫情放假，under consideration 了60天。中间让改格式和动物实验的checklist一次，最终被拒，理由是没有好好回复审稿人的意见。现在备选文章较多，就把我pass了。又气又难过

157 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242219, encodeId=5a121242219b0, content=偏重的研究方向：基础研究;肿瘤分子诊断 经验分享：第九天under consideration，感觉跟别人的投稿进度比，效率有点慢哎，送不送外审要好久哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=219a5283754, createdName=胸心外科大辣鸡, createdTime=Wed Aug 31 09:48:26 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205029, encodeId=f89e120502967, content=现在要求链接所有通讯作者的ORCID号，但是投稿系统只有一个能标通讯作者有链接，另一个咋办啊？还有其他可以添加ORCID号的地方吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/07/6b605841361be17ba96637bccdbdccb4.jpg, createdBy=eaa62374501, createdName=122fdc42m84暂无昵称, createdTime=Tue Mar 22 20:59:37 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544294, encodeId=d79e544294ed, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577327, encodeId=14d55e73276b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2018 IF：5.922；2019 IF：5.416 从今年4月14日投稿，目前还没有online，过了国庆去交版面费（3300刀）做的是分子实验，5张figure+1个table，每个里面有4-7个小figure。附加材料有2张table。等待分配审稿人是最纠结的，大概等了2个月，审稿人意见比较尖锐，补了几个小实验，大概花了半个月在措辞怎么回复审稿人。运气还算好，修回后没有二修就被接收了。杂志对语言要求比较高，一句话编辑让我反复修改了3次才达到要求。投稿 Under submission 14th Apr 19 Author Approved Converted Files 16th Apr 19 Under consideration 16th Apr 19 Under review 13th Jun 19 Under consideration 1st Jul 19 Decision made 2nd Jul 19 Waiting for Revision 2nd Jul 19 Revision Received 23rd Jul 19 修回 Under submission 23rd Jul 19 Author Approved Converted Files 23rd Jul 19 Under consideration 23rd Jul 19 Under review 5th Aug 19 Under consideration 14th Aug 19 Decision made 19th Aug 19 Waiting for Revision 19th Aug 19 Revision Received 19th Aug 19 接收 Under submission 19th Aug 19 Author Approved Converted Files 21st Aug 19 Under consideration 21st Aug 19 Decision made 27th Sep 19, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddf64839631, createdName=chenqun9408, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799863, encodeId=e357e998636f, content=投稿10天，发邮件让提交consent to participate ，然后把国自然的伦理批件提交，过了2天，又给退回还让交consent to participate ，这个怎么破？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Thu Jun 25 21:42:08 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602110, encodeId=26b9602110cb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿6个月被拒了，一修三个审稿人，一个拒两个修改后发表，二修两个审稿人，一个拒一个同意发表，编辑建议英文润色。二修后赶上疫情放假，under consideration 了60天。中间让改格式和动物实验的checklist一次，最终被拒，理由是没有好好回复审稿人的意见。现在备选文章较多，就把我pass了。又气又难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Fri Jun 12 10:54:47 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2023-08-23 火辣辣的夏天来自重庆

偏重的研究方向：肿瘤
经验分享：这个杂志投稿时对格式要求严格吗

37 0

[GetPortalCommentsPageByObjectIdResponse(id=1242219, encodeId=5a121242219b0, content=偏重的研究方向：基础研究;肿瘤分子诊断 经验分享：第九天under consideration，感觉跟别人的投稿进度比，效率有点慢哎，送不送外审要好久哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=219a5283754, createdName=胸心外科大辣鸡, createdTime=Wed Aug 31 09:48:26 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205029, encodeId=f89e120502967, content=现在要求链接所有通讯作者的ORCID号，但是投稿系统只有一个能标通讯作者有链接，另一个咋办啊？还有其他可以添加ORCID号的地方吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/07/6b605841361be17ba96637bccdbdccb4.jpg, createdBy=eaa62374501, createdName=122fdc42m84暂无昵称, createdTime=Tue Mar 22 20:59:37 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544294, encodeId=d79e544294ed, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577327, encodeId=14d55e73276b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2018 IF：5.922；2019 IF：5.416 从今年4月14日投稿，目前还没有online，过了国庆去交版面费（3300刀）做的是分子实验，5张figure+1个table，每个里面有4-7个小figure。附加材料有2张table。等待分配审稿人是最纠结的，大概等了2个月，审稿人意见比较尖锐，补了几个小实验，大概花了半个月在措辞怎么回复审稿人。运气还算好，修回后没有二修就被接收了。杂志对语言要求比较高，一句话编辑让我反复修改了3次才达到要求。投稿 Under submission 14th Apr 19 Author Approved Converted Files 16th Apr 19 Under consideration 16th Apr 19 Under review 13th Jun 19 Under consideration 1st Jul 19 Decision made 2nd Jul 19 Waiting for Revision 2nd Jul 19 Revision Received 23rd Jul 19 修回 Under submission 23rd Jul 19 Author Approved Converted Files 23rd Jul 19 Under consideration 23rd Jul 19 Under review 5th Aug 19 Under consideration 14th Aug 19 Decision made 19th Aug 19 Waiting for Revision 19th Aug 19 Revision Received 19th Aug 19 接收 Under submission 19th Aug 19 Author Approved Converted Files 21st Aug 19 Under consideration 21st Aug 19 Decision made 27th Sep 19, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddf64839631, createdName=chenqun9408, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799863, encodeId=e357e998636f, content=投稿10天，发邮件让提交consent to participate ，然后把国自然的伦理批件提交，过了2天，又给退回还让交consent to participate ，这个怎么破？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Thu Jun 25 21:42:08 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602110, encodeId=26b9602110cb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿6个月被拒了，一修三个审稿人，一个拒两个修改后发表，二修两个审稿人，一个拒一个同意发表，编辑建议英文润色。二修后赶上疫情放假，under consideration 了60天。中间让改格式和动物实验的checklist一次，最终被拒，理由是没有好好回复审稿人的意见。现在备选文章较多，就把我pass了。又气又难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Fri Jun 12 10:54:47 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2023-05-25 阿曾曾曾曾来自上海

收回顾性文章吗.......

63 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务